ANNX vs ARDX: stock comparison and AI forecast
Annexon, Inc. (ANNX) and Ardelyx, Inc. (ARDX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ANNX Annexon, Inc.
- Market Cap
- $759M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
ARDX Ardelyx, Inc.
- Market Cap
- $745M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ANNX and ARDX have similar market capitalizations ($759M and $745M).
- ARDX carries 2.58 times debt per unit of equity, against 0.31 times for ANNX.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ANNX | ARDX |
|---|---|---|
| Market Cap | $759M | $745M |
| P/B Ratio | 3.59x | 4.54x |
| EPS | $-1.28 | $-0.26 |
| Book Value/Share | $1.12 | $0.66 |
| Revenue/Share | – | $1.88 |
| FCF/Share | $-1.02 | $-0.06 |
Profitability & Margins
| Metric | ANNX | ARDX |
|---|---|---|
| ROE | -91.4% | -33.8% |
| ROA | – | -9.4% |
| ROIC | – | -7.8% |
| Gross Margin | – | 94.5% |
| Operating Margin | – | -7.7% |
| Net Margin | – | -11.8% |
| EBT Margin | – | -11.8% |
| Tax Rate | – | -0.4% |
Financial Health
| Metric | ANNX | ARDX |
|---|---|---|
| Current Ratio | 5.53x | 3.45x |
| Quick Ratio | – | 2.22x |
| D/E Ratio | 0.31x | 2.58x |
| Financial Leverage | – | 3.58x |
| Interest Coverage | – | 0.8x |
| Working Capital | $174M | $314M |
Cash Flow
| Metric | ANNX | ARDX |
|---|---|---|
| Operating Cash Flow | -$193M | -$16M |
| Free Cash Flow | -$193M | -$16M |
| Capital Spending | -$180K | -$440K |
| FCF/Sales | – | -3.4% |
| CapEx/Sales | – | 0.1% |
Operational Efficiency
| Metric | ANNX | ARDX |
|---|---|---|
| Asset Turnover | – | 0.80x |
| Receivables Turnover | – | 5.0x |
| Inventory Turnover | – | 0.2x |
| Fixed Assets Turnover | – | 298.2x |
| Days Sales Outstanding | – | 73 days |
| Days Inventory | – | 2215 days |
| Payables Period | – | 473 days |
| Cash Conversion Cycle | – | 1815 days |
Income Statement
| Metric | ANNX | ARDX |
|---|---|---|
| Total Revenue | – | $468M |
| Operating Income | -$211M | -$36M |
| Net Income | -$193M | -$55M |
| R&D Expense | $175M | $94M |
| SG&A Expense | – | $384M |
| Cost of Goods Sold | – | $26M |
Dividend & Shareholder Information
| Metric | ANNX | ARDX |
|---|---|---|
| Shares Outstanding | 190M | 249M |
ANNX vs ARDX: stock comparison and AI forecast
Which is bigger, ANNX or ARDX?
ANNX and ARDX have similar market capitalizations ($759M and $745M).
Which one does Intratio's AI model rank higher, ANNX or ARDX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.